Uploaded September 2022 | Updated September 2026, 3 days ago

---

At the EASD 2022 Annual Meeting, experts Dr Maciej Malecki and Dr Mina Mitraku debate whether Continuous Glucose Monitoring (CGM) should be available for all diabetes patients. Is it cost-effective? Should it be more widely accessible for both Type 1 and Type 2 diabetes? Watch this insightful discussion to learn more about the future of CGM technology and its impact on diabetes care! 🌍💉

#DiabetesCare #EASD2022 #Diabetes #ContinuousGlucoseMonitoring #DiabetesManagement #FutureOfCGM #Type1Diabetes #Type2Diabetes #HealthcareInnovation #PatientCare #DiabetesTechnology